DNA methylation-regulated microRNA pathways in ovarian serous cystadenocarcinoma: A meta-analysis |
| |
| Institution: | 1. Department of Bioinformatics and Medical Engineering, Asia University, Taichung 41354, Taiwan;2. Department of Computer Science and Information Engineering, National Formosa University, 632, Taiwan;3. Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan;4. Human Genetic Center, China Medical University Hospital, Taichung 40447, Taiwan;5. School of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung 40201, Taiwan;6. School of Information Technology, Mae Fah Luang University, 57100, Thailand;7. Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan;1. Researcher, Department of Stomatology, General Hospital of the Chengdu Military Command, Chengdu, China;2. Researcher, Department of Respiratory Medicine, General Hospital of the Chengdu Military Command, Chengdu, China;3. Researcher, Department of Stomatology, General Hospital of the Chengdu Military Command, Chengdu, China;4. Researcher, Department of Stomatology, General Hospital of the Chengdu Military Command, Chengdu, China;1. Department of Obstetrics and Gynecology, “Angelo Nocivelli” Institute of Molecular Medicine, University of Brescia, Brescia, Italy;2. Doctorate School of Molecular and Translational Medicine, University of Milano, Milano, Italy;3. Department of Biology, University of Padova, Padova, Italy;4. Department of Oncology, IRCCS – “Mario Negri” Institute for Pharmacological Research, Milano, Italy;5. Department of Experimental, Diagnostic and Specialty Medicine – DIMES, University of Bologna, Bologna, Italy;6. Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Catholic University of the Sacred Heart, Rome, Italy;7. Division of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, Brescia, Italy;8. Department of Obstetrics and Gynecology, University of Brescia, Brescia, Italy;9. Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy;1. Department of Children Rehabilitation, Women & Children’s Health Care Hospital of Linyi, Linyi 276016, Shandong, China;2. Children''s Hospital of Kaifeng City, Kaifeng 475000, Henan, China;3. Department of Child Health Care, Women & Children’s Health Care Hospital of Linyi, Linyi 276016, Shandong, China;1. Department of Cell Biology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China;2. Peking University Stem Cell Research Center, China National Center for International Research, Peking University Health Science Center, Beijing 100191, China;3. SARI Center for Stem Cell and Nanomedicine, Shanghai Advanced Research Institute, University of Chinese Academy of Sciences, Shanghai 200120, China |
| |
| Abstract: | Epigenetic regulation has been linked to the initiation and progression of cancer. Aberrant expression of microRNAs (miRNAs) is one such mechanism that can activate or silence oncogenes (OCGs) and tumor suppressor genes (TSGs) in cells. A growing number of studies suggest that miRNA expression can be regulated by methylation modification, thus triggering cancer development. However, there is no comprehensive in silico study concerning miRNA regulation by direct DNA methylation in cancer. Ovarian serous cystadenocarcinoma (OSC) was therefore chosen as a tumor model for the present work.Twelve batches of OSC data, with at least 35 patient samples in each batch, were obtained from The Cancer Genome Atlas (TCGA) database. The Spearman rank correlation coefficient (SRCC) was used to quantify the correlation between the CpG DNA methylation level and miRNA expression level. Meta-analysis was performed to reduce the effects of biological heterogeneity among different batches. MiRNA-target interactions were also inferred by computing SRCC and meta-analysis to assess the correlation between miRNA expression and cancer-associated gene expression and the interactions were further validated by a query against the miRTarBase database.A total of 26 potential epigenetic-regulated miRNA genes that can target OCGs or TSGs in OSC were found to show biological relevance between DNA methylation and miRNA gene expression. Furthermore, some of the identified DNA-methylated miRNA genes; for instance, the miR-200 family, were previously identified as epigenetic-regulated miRNAs and correlated with poor survival of ovarian cancer. We also found that several miRNA target genes, BTG3, NDN, HTRA3, CDC25A, and HMGA2 were also related to the poor outcomes in ovarian cancer.The present study proposed a systematic strategy to construct highly confident epigenetic-regulated miRNA pathways for OSC. The findings are validated and are in line with the literature. The inclusion of direct DNA methylated miRNA events may offer another layer of explanation that along with genetics can give a better understanding of the carcinogenesis process. |
| |
| Keywords: | Epigenetic microRNA DNA methylation CpG islands Ovarian cancer Meta-analysis |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
